Your browser doesn't support javascript.
Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways.
Rajpal, Saurabh; Kahwash, Rami; Tong, Matthew S; Paschke, Kelly; Satoskar, Anjali A; Foreman, Beth; Allen, Larry A; Bhave, Nicole M; Gluckman, Ty J; Fuster, Valentin.
  • Rajpal S; Division of Cardiology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Electronic address: Saurabh.Rajpal@osumc.edu.
  • Kahwash R; Division of Cardiology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Tong MS; Division of Cardiology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Paschke K; Division of Cardiology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Satoskar AA; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Foreman B; Division of Cardiology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Allen LA; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Bhave NM; Division of Cardiology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
  • Gluckman TJ; Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, Oregon, USA.
  • Fuster V; The Zena and Michael Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
J Am Coll Cardiol ; 79(21): 2144-2152, 2022 05 31.
Article in English | MEDLINE | ID: covidwho-1859823
ABSTRACT
A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracorporeal Membrane Oxygenation / COVID-19 / Myocarditis Type of study: Case report / Diagnostic study / Prognostic study Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Journal: J Am Coll Cardiol Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracorporeal Membrane Oxygenation / COVID-19 / Myocarditis Type of study: Case report / Diagnostic study / Prognostic study Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Journal: J Am Coll Cardiol Year: 2022 Document Type: Article